Contraceptive Pills Market

Contraceptive Pills Market Finds Growth as Awareness Generates Positive Outcomes

The global contraceptive pills market has opened new avenues not only for birth control but also for treatment of menstrual disorders in women. Rising awareness about unprotected sex amongst young generation coupled with ease availability of over the counter emergency contractive pills has boosted the growth of global contraceptive pills market. Moreover, strong epidemiological studies has reported almost 50 per cent reduction in endometrial cancer among women who opted for oral combined pills as compared to those who never used any combined contraceptive pills. The positive outcomes of oral contraceptive pills has boosted the global demand, says Fairfield Market Research.

Choice of Delayed Pregnancies Piques Interest in Global Contraceptive Pills Market

Various birth control methods are widely available in the contraceptives market with multiple choices including male female condoms, diaphragms, contraceptive implants/depots, contraceptive patches, and contraceptive pills. However, the contraceptive drugs mainly includes oral contraceptives, injectables, and topical options. The global contraceptive pills market is expected to reach a valuation of US$16.1 Bn in 2022 and is expected to reach US$26.5 Bn by 2028, registering a CAGR of 6.1% during the forecast period.

The target audience for contraceptive pills are women between ages of 15 to 44 years. Growing urge to pursue education and career achievements have shifted the mindset towards delayed pregnancies prompting women to use contraceptive pills. Furthermore, growing sex education and awareness of contraceptive methods among the teenage groups have augured well for global market in recent years.

COVID-19 had a huge negative impact in growth of the global contraceptive pills market as many women could not access the pharmacies and healthcare centers to procure these medicines. Moreover, commercial supply chains were significantly affected thus limiting the supply of these medicines to medical stores due to lockdown situation.

Certain long term side effects to contraceptive pills such as irregular menstrual bleeding, nausea, headache, and dizziness has compelled some of the user population to adopt other contraceptive options such as acid based vaginal rings like Phexii (by Evofem Biosciences) and Ovaprene (Dare Biosciences) as an alternative to hormonal chemical compounds. However, these methods are not as dependable as oral contraceptive pills. These factors are expected to act as impediments to the expansion of the global contraceptive pill market.

Non-Contraceptive Uses of Contraceptive Pills Emerges as Essential Market Driver

The global contraceptive pills market has been thriving as the product offers many benefits apart from birth control. Most of the birth control pills provide pills for three weeks which is followed by one week of placebo pills or iron supplements. Menses occur in women when they stop the birth control pills after three weeks. Certain companies make pills that contain pill packs for three months of continuous active pills due to which women can have menses only four times a year. This becomes extremely helpful for girls who undertake heavy sports activities, exams, and social events.

Global contraceptive pills market also finds its application in treatment of irregular menses and polycystic ovarian syndrome. Since birth control pills contains progesterone similar compounds it are beneficial in maintaining the uterine lining. Menstrual irregularities such as menorrhagia (heavy menses) and dysmenorrhea (painful menses) are being well managed through use of contraceptive pills. The contraceptive pills have also been instrumental in treatment of another major painful gynecological condition called endometriosis, premenstrual syndrome, and premenstrual dysphoric by preventing ovulation.

Contraceptive pills have significantly helped women who have reported to have high levels of androgens (male hormones) causing hirsutism. Hirsutism is a condition which female’s sensitivity to androgens cause excessive hair growth and acne.

North America Dominates as Awareness Finds More Buyers

North America accounted for the largest share which is followed by Europe. US which accounts for largest market share in North America reported to have highest usage of contraceptive pills as birth control method. According to National Library of Medicine (NIH) 2022, approximately 25% of women in age group of 15 to 44 used contraceptive pills as their preference for birth control. Combination pills (contains estrogen-progesterone) or Only Progesterone pill (POP) are familiar and popularly used in the country. There has been a significant rise in use of emergency contraceptive pills across all the age groups especially women aged 20-29 and those who never given birth. Moreover, over the counter availability of emergency pill for unprotected sex has enormously boosted the demand for contraceptive pills not only in US but worldwide.

The Affordable Act 2013 of President Obama, framed birth control mandate post which there has been significant drop in number of women with out of pocket expenses. This expense dropped significantly from 21% to 3% since 2013. Growing awareness of unprotected sex, unwanted pregnancies amongst teenage population across the U.S. has boosted the growth of contraceptives market in the country. Asia Pacific region is expected to foresee higher growth owing to growing awareness and initiatives undertaken by government through advertisements and campaigns towards population control.

Competitive Landscape: Global Contraceptive Pills Market

The major players in the global contraceptive pills market include Agile Therapeutics, Allergan Plc., Bayer AG, GlaxoSmithKline Plc, Johnson & Johnson, Piramal Healthcare, Mylan NV, Pfizer Inc., Novartis AG, and Teva Pharmaceuticals. Recently in April 2021, Mayne Pharma Group Limited and Mithra Pharmaceuticals announced US FDA approval NDA for novel combined oral contraceptive pill named “Estelle” and will be marketed under the trade name of “Nextstellis”. Developed by Mithra Pharma, Nextstellis, is the first and only contraceptive pill containing estetrol, a native estrogen derived from a plant source. Estetrol is the first new estrogen introduced in the U.S. in more than 50 years.

Global Contraceptive Pills Market is Segmented as Below:

By Product

• Oral Contraceptive Pills
• Injectable Contraceptives
• Topical Contraceptives

By Age Group

• 15–24 years
• 25–34 years
• 35–44 years
• Above 44 years

By End User

• Homecare
• Hospitals
• Clinics

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Rest of Europe
• Asia-Pacific
• Japan
• China
• Australia
• India
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

Key Elements Included In The Study: Global Contraceptive Pills Market

• Contraceptive Pills Market by Product/Technology/Grade, Application/End-user, and Region
• Executive Summary (Opportunity Analysis and Key Trends)
• Historical Market Size and Estimates, Value, 2018 - 2021
• Market Value at Regional and Country Level, 2022 - 2029
• Market Dynamics and Economic Overview
• Market Size in Value, Growth Rates, and Forecast Figures, 2022 - 2029
• Competitive Intelligence with Financials, Key Developments, and Portfolio of Leading Companies 
• Regional and Product/Grade/Application/End-user Price Trends Analysis
• Value Chain and Five Force’s Analysis
• Regional/Sub-region/Country Market Size and Trend Analysis
• Company Market Share Analysis and Key Player Profiles

Post Sale Support, Research Updates & Offerings

We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.

• The report will be prepared in a PPT format and will be delivered in a PDF format.

• Additionally, Market Estimation and Forecast numbers will be shared in Excel Workbook.

• If a report being sold was published over a year ago, we will offer a complimentary copy of the updated research report along with Market Estimation and Forecast numbers within 2-3 weeks’ time of the sale.

• If we update this research study within the next 2 quarters, post purchase of the report, we will offer a Complimentary copy of the updated Market Estimation and Forecast numbers in Excel Workbook.

• If there is a geopolitical conflict, pandemic, recession, and the like which can impact global economic scenario and business activity, which might entirely alter the market dynamics or future projections in the industry, we will create a Research Update upon your request at a nominal charge.

Disclaimer:

• The segmentation/company profiles/countries depicted above may vary in the actual report.